Squarepoint’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $91.9M | Buy |
1,672,447
+283,719
| +20% | +$15.6M | 0.1% | 115 |
|
2025
Q1 | $98.2M | Buy |
1,388,728
+695,590
| +100% | +$49.2M | 0.12% | 80 |
|
2024
Q4 | $45.6M | Buy |
693,138
+488,612
| +239% | +$32.1M | 0.04% | 181 |
|
2024
Q3 | $14.4M | Buy |
204,526
+100,841
| +97% | +$7.09M | 0.02% | 387 |
|
2024
Q2 | $8.54M | Sell |
103,685
-757,532
| -88% | -$62.4M | 0.01% | 511 |
|
2024
Q1 | $75.2M | Buy |
861,217
+582,506
| +209% | +$50.9M | 0.13% | 64 |
|
2023
Q4 | $26.9M | Sell |
278,711
-177,477
| -39% | -$17.1M | 0.05% | 207 |
|
2023
Q3 | $40.4M | Buy |
456,188
+138,897
| +44% | +$12.3M | 0.1% | 129 |
|
2023
Q2 | $27.5M | Buy |
317,291
+145,932
| +85% | +$12.6M | 0.08% | 159 |
|
2023
Q1 | $16.7M | Sell |
171,359
-3,774
| -2% | -$367K | 0.07% | 205 |
|
2022
Q4 | $18.1M | Buy |
175,133
+151,541
| +642% | +$15.7M | 0.07% | 179 |
|
2022
Q3 | $2M | Buy |
+23,592
| New | +$2M | 0.01% | 786 |
|
2022
Q2 | – | Sell |
-218,758
| Closed | -$16.9M | – | 2149 |
|
2022
Q1 | $16.9M | Sell |
218,758
-38,713
| -15% | -$2.98M | 0.07% | 203 |
|
2021
Q4 | $22.7M | Buy |
257,471
+60,156
| +30% | +$5.31M | 0.06% | 160 |
|
2021
Q3 | $15.3M | Buy |
197,315
+108,567
| +122% | +$8.39M | 0.04% | 205 |
|
2021
Q2 | $7.41M | Sell |
88,748
-37,305
| -30% | -$3.11M | 0.03% | 364 |
|
2021
Q1 | $9.52M | Buy |
126,053
+68,303
| +118% | +$5.16M | 0.06% | 250 |
|
2020
Q4 | $5.06M | Buy |
57,750
+31,884
| +123% | +$2.8M | 0.04% | 390 |
|
2020
Q3 | $1.97M | Sell |
25,866
-43,736
| -63% | -$3.33M | 0.03% | 631 |
|
2020
Q2 | $8.59M | Sell |
69,602
-51,583
| -43% | -$6.36M | 0.14% | 206 |
|
2020
Q1 | $10.2M | Sell |
121,185
-241,492
| -67% | -$20.4M | 0.26% | 77 |
|
2019
Q4 | $30.7M | Buy |
362,677
+301,244
| +490% | +$25.5M | 0.18% | 89 |
|
2019
Q3 | $4.14M | Sell |
61,433
-58,184
| -49% | -$3.92M | 0.04% | 525 |
|
2019
Q2 | $10.2M | Buy |
119,617
+13,582
| +13% | +$1.16M | 0.1% | 245 |
|
2019
Q1 | $9.42M | Buy |
106,035
+101,802
| +2,405% | +$9.04M | 0.1% | 246 |
|
2018
Q4 | $360K | Buy |
+4,233
| New | +$360K | ﹤0.01% | 1396 |
|
2017
Q4 | – | Sell |
-55,529
| Closed | -$5.17M | – | 2080 |
|
2017
Q3 | $5.17M | Buy |
+55,529
| New | +$5.17M | 0.1% | 260 |
|
2016
Q4 | – | Sell |
-2,800
| Closed | -$259K | – | 1768 |
|
2016
Q3 | $259K | Sell |
2,800
-8,327
| -75% | -$770K | 0.02% | 792 |
|
2016
Q2 | $866K | Buy |
+11,127
| New | +$866K | 0.05% | 393 |
|
2016
Q1 | – | Sell |
-6,800
| Closed | -$712K | – | 1179 |
|
2015
Q4 | $712K | Sell |
6,800
-798
| -11% | -$83.6K | 0.08% | 368 |
|
2015
Q3 | $800K | Buy |
+7,598
| New | +$800K | 0.2% | 139 |
|
2015
Q2 | – | Sell |
-7,200
| Closed | -$897K | – | 469 |
|
2015
Q1 | $897K | Buy |
+7,200
| New | +$897K | 0.31% | 104 |
|